VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC
Titel:
VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC
Auteur:
Hochmair, M.J. Vermaelen, K. Mountzios, G. Carcereny, E. Dooms, C. Lee, S-H. Morocz, E.M. Kato, T. Ciuleanu, T-E. Dy, G. Parente, M.B.M.C.S. O'Byrne, K.J. Chu, Q.S-C. De Castro Jr., G. Girard, N. Snyder, W. Tran, Q. Kormany, W. Houk, B. Curioni-Fontecedro, A.